Teladoc Health, Inc. TDOC R2K

Healthcare · Health Information Services · United States

https://www.teladochealth.com

Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, and mental health services, as well as technologies and enterprise telehealth solutions for hospitals and health systems. Its BetterHelp segment operates a mental health platform that provides online counselling and therapy services through websites, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc and BetterHelp brands. It serves employers, health plans, hospitals and health systems, insurance companies, and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in New York, New York.

Market & Price

Market Cap

$1.37B

Current Price

$7.61

High / Low (52W)

$9.46 / $4.47

Beta

2.08

Valuation

Stock P/E

Industry PE

23.65

Forward P/E

PEG Ratio

Book Value

$7.77

Price to Book

0.98

P/S

0.55

EV/EBITDA

34.96

Dividend Yield

Profitability & Returns

ROCE

-8.80%

ROE

-12.39%

ROA

-3.14%

Profit Margin

-6.81%

Op Margin

-7.94%

EPS (Latest Qtr)

$-10.80

EPS (TTM)

$-0.97

Balance Sheet & Liquidity

Debt/Equity

0.78

Quick Ratio

2.40

Current Ratio

2.80

Debt

$1.04B

Total Assets

$2.86B

Current Assets

$1.12B

Working Capital

$714.39M

Ownership

Promoter Holding

0.70%

Chg in Prom Hold

FII / Inst Holding

81.75%

Chg in FII Hold

Financial Snapshot

Enterprise Value

$1.66B

Total Revenue (TTM)

$2.51B

EBITDA

$47.51M

Free Cash Flow

$208.26M

Operating Cash Flow

$287.95M

Shares Outstanding

180.51M

Gross Margin

69.29%

Payout Ratio

0.00%

Growth (CAGR)

Revenue 5Y

1.68%

Profit 5Y

32.84%

Revenue (YoY)

-2.50%

Earnings (YoY)

PROS

Profit CAGR of 32.8% over 5 years.
Generates positive free cash flow.

CONS

In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	TDOC Teladoc Health, Inc. R2K	7.61	-	$1.37B	-	-8.80%	-12.39%	1.68%	32.84%
2	LLY Eli Lilly and Company SPX	1,105.00	39.21	$985.37B	0.63%	38.44%	107.46%	31.69%	48.96%
3	JNJ Johnson & Johnson SPX	225.33	26.11	$542.42B	2.38%	23.13%	26.42%	5.60%	14.32%
4	UNH UnitedHealth Group Incorporated SPX	380.31	28.66	$345.38B	2.32%	9.60%	12.18%	11.35%	-15.69%
5	MRK Merck & Co., Inc. SPX	118.72	33.44	$293.22B	2.86%	20.66%	18.94%	3.12%	7.93%
6	TMO Thermo Fisher Scientific Inc. SPX	492.51	27.11	$183.03B	0.38%	9.17%	13.52%	-0.27%	-1.19%
7	AMGN Amgen Inc. NDXSPX	336.79	23.42	$181.77B	2.99%	18.02%	101.32%	11.77%	5.58%
8	GILD Gilead Sciences, Inc. NDXSPX	134.43	18.29	$166.90B	2.44%	22.92%	43.36%	2.57%	22.83%
9	ISRG Intuitive Surgical, Inc. NDXSPXAI	424.64	51.53	$150.39B	-	15.96%	17.23%	17.39%	29.26%

Quarterly Results

Figures in USD.

Metric	Sep 2014	Mar 2015	Jun 2015	Sep 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	503.14M	521.66M	565.35M	592.38M	611.40M	629.24M	652.41M	660.24M	646.13M	642.44M	640.51M	629.37M	631.90M	626.44M	642.27M	613.85M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	196.83M	190.54M	187.18M	197.05M	197.53M
Gross Profit	8.75M	11.21M	13.49M	15.48M	18.95M	19.60M	25.27M	27.38M	30.76M	34.56M	51.91M	54.42M	62.79M	66.88M	76.80M	82.71M	83.90M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	432.54M	441.36M	439.26M	445.22M	416.32M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	487.48M	487.40M	474.72M	472.19M	465.05M
Operating Income	-3.86M	-12.59M	-16.25M	-12.60M	-14.71M	-14.46M	-20.26M	-13.23M	-14.80M	-14.49M	-21.54M	-24.56M	-19.09M	-18.15M	-15.78M	-17.84M	-22.89M	-22.02M	-19.94M	-15.59M	-21.01M	-7.18M	-19.73M	-84.68M	-78.95M	-60.58M	-6.67B	-3.10B	-71.73M	-77.10M	-71.64M	-64.72M	-87.12M	-841.15M	-44.40M	-54.94M	-46.03M	-35.46M	-26.97M	-48.73M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-15.33M	58.94M	46.46M	70.55M	38.71M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5.76M	4.47M	4.53M	4.95M	5.37M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-111.27M	-40.42M	-50.22M	-33.62M	-60.84M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-18.25M	-7.76M	-715.00K	-8.47M	3.00M
Net Income	-4.53M	-12.70M	-17.06M	-13.25M	-15.30M	-14.88M	-29.77M	-14.26M	-15.65M	-15.41M	-31.33M	-44.38M	-23.86M	-25.08M	-23.26M	-24.88M	-30.15M	-29.32M	-20.35M	-19.04M	-29.60M	-25.68M	-35.88M	-199.65M	-133.82M	-84.34M	-6.67B	-3.10B	-73.48M	-69.23M	-65.18M	-57.07M	-81.89M	-837.67M	-33.28M	-93.01M	-32.66M	-49.51M	-25.14M	-63.84M
Diluted EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.31	-0.86	-0.53	-41.58	-19.22	-0.45	-0.42	-0.40	-0.35	-0.49	-4.92	-0.19	-15.90	-5.70	-8.40	-4.20	-10.80
R&D Expense	1.96M	2.91M	3.20M	3.94M	5.22M	4.83M	5.87M	5.89M	6.51M	7.54M	9.96M	10.45M	12.90M	14.35M	13.58M	13.54M	15.99M	16.66M	15.75M	16.25M	19.26M	23.03M	29.96M	78.01M	80.76M	80.25M	87.41M	78.70M	84.59M	86.98M	87.31M	84.29M	81.39M	76.75M	72.38M	69.96M	68.78M	67.57M	-	67.86M

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	-	-	-	-	-	-	-	1.09B	-	2.41B	2.60B	2.57B	2.53B
Cost of Revenue	-	-	-	-	-	-	-	-	-	743.99M	760.03M	751.27M	771.59M
Gross Profit	15.72M	33.60M	56.34M	91.19M	171.66M	289.17M	-	-	-	1.66B	1.84B	1.82B	1.76B
Operating Expenses	-	-	-	-	-	-	-	-	-	1.89B	2.05B	2.03B	1.92B
Operating Income	-5.87M	-15.15M	-55.78M	-62.66M	-75.39M	-70.85M	-80.44M	-506.42M	-	-227.37M	-210.50M	-208.79M	-163.40M
EBITDA	-	-	-	-	-	-	-	-	-	-13.37B	151.40M	-587.01M	160.62M
Interest Expense	-	-	-	-	-	-	-	-	-	21.94M	22.28M	23.80M	19.71M
Pretax Income	-	-	-	-	-	-	-	-	-	-13.66B	-219.61M	-993.65M	-235.53M
Tax Provision	-	-	-	-	-	-	-	-	-	-3.81M	760.00K	7.59M	-35.21M
Net Income	-6.02M	-17.04M	-58.02M	-74.22M	-106.78M	-97.08M	-98.86M	-485.14M	-	-13.66B	-220.37M	-1.00B	-200.32M
Diluted EPS	-	-	-	-	-	-	-1.38	-5.36	-	-2,538.00	-40.20	-176.10	-34.20
R&D Expense	3.53M	7.57M	14.21M	21.82M	34.46M	54.37M	64.64M	164.94M	311.88M	333.63M	348.52M	307.27M	277.92M

Compounded Sales Growth

5 Years:	1.68%
1 Year:	-2.50%

Compounded Profit Growth

5 Years:	32.84%
1 Year:	-

Stock Price Performance

1 Year:	+9.97%
6 Months:	+2.01%
3 Months:	+44.68%
1 Month:	+27.90%

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	91.84M	229.74M	303.67M	824.39M	1.53B	1.60B	17.76B	-	4.35B	4.39B	3.52B	2.86B
Current Assets	-	-	-	-	-	-	-	-	-	-	1.32B	1.49B	1.66B	1.12B
Cash & Equivalents	8.69M	3.21M	46.44M	55.07M	50.02M	42.82M	423.99M	514.35M	733.32M	-	918.18M	1.12B	1.30B	781.08M
Inventory	-	-	-	-	-	-	-	-	-	-	56.34M	29.51M	38.14M	38.20M
Receivables	-	-	-	-	-	-	-	-	-	-	210.55M	217.42M	214.15M	192.83M
Total Liabilities	-	-	-	-	-	-	-	-	-	-	2.04B	2.07B	2.03B	1.47B
Current Liabilities	-	-	10.32M	17.99M	21.07M	40.33M	62.44M	90.18M	332.65M	-	399.77M	420.62M	941.53M	404.74M
Long Term Debt	-	-	25.04M	25.23M	42.42M	-	-	-	-	-	1.54B	1.54B	991.42M	994.92M
Total Debt	-	-	-	-	-	-	-	-	-	-	1.59B	1.59B	1.58B	1.04B
Total Equity	-46.53M	-55.45M	-67.53M	178.56M	230.87M	558.90M	1.01B	1.01B	15.88B	-	2.31B	2.33B	1.49B	1.39B
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	162.84M	166.66M	173.41M	178.32M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	-	-	-47.18M	-51.88M	-34.44M	-4.86M	29.87M	-53.51M	-	189.29M	350.02M	293.68M	294.36M
Investing Cash Flow	-	-	-108.20M	26.15M	-448.38M	-257.50M	25.01M	-590.98M	-	-167.74M	-156.35M	-124.05M	-266.00M
Financing Cash Flow	-	-	164.01M	20.68M	475.43M	645.61M	35.09M	859.14M	-	6.50M	10.85M	8.31M	-551.65M
Capital Expenditure	-204.00K	-1.07M	-6.28M	-2.11M	-2.63M	-4.01M	-3.51M	-4.02M	-	-172.76M	-156.35M	-124.05M	-157.02M
Free Cash Flow	-	-	-53.46M	-53.98M	-37.07M	-8.87M	26.36M	-57.53M	-	16.53M	193.67M	169.63M	137.33M
Net Change in Cash	-	-	-	-	-	-	-	-	-	28.05M	204.53M	177.94M	-523.30M
Share Buybacks	71.00K	368.00K	-	-	-	-	-	-	-	-	-	-	-

Ratios (Annual)

Figures in %.

Metric	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	-	-	-	-	69.1%	70.8%	70.8%	69.5%
Operating Margin %	-	-	-	-	-	-	-	-46.3%	-	-9.4%	-8.1%	-8.1%	-6.5%
Net Margin %	-	-	-	-	-	-	-	-44.3%	-	-567.5%	-8.5%	-39.0%	-7.9%
ROE %	10.9%	25.2%	-32.5%	-32.1%	-19.1%	-9.6%	-9.7%	-3.1%	-	-591.9%	-9.5%	-67.1%	-14.5%
ROCE %	-	-18.6%	-26.3%	-22.2%	-9.6%	-4.8%	-5.3%	-2.9%	-	-5.8%	-5.3%	-8.1%	-6.7%

Shareholding Pattern

Insiders

0.70%

Institutions

81.75%

Public Float

82.33%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Blackrock Inc.	8.10%	14.61M	$111.21M
2	Vanguard Portfolio Management LLC	6.81%	12.30M	$93.57M
3	Renaissance Technologies, LLC	4.48%	8.09M	$61.53M
4	Vanguard Capital Management LLC	4.35%	7.86M	$59.79M
5	Point72 Asset Management, L.P.	4.28%	7.72M	$58.76M
6	Dimensional Fund Advisors LP	3.49%	6.30M	$47.93M
7	Allianz Asset Management GmbH	2.65%	4.79M	$36.46M
8	State Street Corporation	2.42%	4.36M	$33.18M
9	Voss Capital, LP	2.33%	4.20M	$31.96M
10	Geode Capital Management, LLC	2.32%	4.18M	$31.81M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for TDOC

No recent headlines available.

TDOC · Healthcare